Next Article in Journal
From Evidence to Practice: The Growing Role of Angiography-Derived Physiology
Previous Article in Journal
Smoking Amplifies Comorbidity-Associated Risk in Orthopaedic Surgery: A Multiplicative Interaction
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Dursun et al. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927

1
Department of Medical Oncology, Ankara University Faculty of Medicine, 06100 Ankara, Turkey
2
Department of Medical Oncology, Ankara Etlik City Training and Research Hospital, 06010 Ankara, Turkey
3
Department of Nuclear Medicine, Şanlıurfa Mehmet Akif Inan Education and Research Hospital, 63200 Sanlıurfa, Turkey
4
Department of Nuclear Medicine, Ankara University Faculty of Medicine, 06100 Ankara, Turkey
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(22), 8218; https://doi.org/10.3390/jcm14228218
Submission received: 2 October 2025 / Accepted: 30 October 2025 / Published: 20 November 2025
(This article belongs to the Section Oncology)

Additional Affiliation

In published publication [1], there was an error regarding the affiliations for Bengu Dursun. Due to an oversight during the submission process, Bengu Dursun’s institutional affiliations were omitted. In addition to affiliation 2, the updated affiliations should include affiliation 1. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Dursun, B.; Demir, B.; Öksüz, N.E.; Soydal, Ç.; Utkan, G. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dursun, B.; Demir, B.; Öksüz, N.E.; Soydal, Ç.; Utkan, G. Correction: Dursun et al. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927. J. Clin. Med. 2025, 14, 8218. https://doi.org/10.3390/jcm14228218

AMA Style

Dursun B, Demir B, Öksüz NE, Soydal Ç, Utkan G. Correction: Dursun et al. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927. Journal of Clinical Medicine. 2025; 14(22):8218. https://doi.org/10.3390/jcm14228218

Chicago/Turabian Style

Dursun, Bengu, Burak Demir, Nejat Emre Öksüz, Çiğdem Soydal, and Güngör Utkan. 2025. "Correction: Dursun et al. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927" Journal of Clinical Medicine 14, no. 22: 8218. https://doi.org/10.3390/jcm14228218

APA Style

Dursun, B., Demir, B., Öksüz, N. E., Soydal, Ç., & Utkan, G. (2025). Correction: Dursun et al. TARE-Induced Pan-Immune Inflammation Value as a Prognostic Biomarker in Liver-Dominant Metastatic Colorectal Cancer. J. Clin. Med. 2025, 14, 4927. Journal of Clinical Medicine, 14(22), 8218. https://doi.org/10.3390/jcm14228218

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop